Steven Middleton
Postdoctoral Research Scientist
- Research Fellow, Wolfson College
Biography
I received my BSc (Hons) in Neuroscience from Cardiff University, my research focused on the peripheral nervous system and sensory neuron development with Professor Alun Davies. I completed a research training year at the Max Delbrück Centre for Molecular Medicine, in Berlin. I worked under the supervision of Professor Gary Lewin studing mechanisms of touch sensation. My doctoral training was completed at the University of Oxford. My Wellcome Trust DPhil Studentship investigated the role of Ion Channels in Health & Disease (OXION) with a focus on chronic pain. During my DPhil I received training from the Neural Injury Group (Oxford), the Max Delbrück Centre for Molecular Medicine (Berlin) and the University of New England (Maine, US).
I am currently a senior post-doctoral research scientist in the Neural Injury Research Group led by Professor David Bennett, and Research Fellow at Wolfson College.
Research Summary
My research focuses on the neurobiology of pain and touch sensation. In particular, my work interrogates the functional role of different populations of sensory neurons. Sensory neurons are heterogeneous nerve cells that innervate sensory targets such as the skin, and extend central terminals which enter the dorsal horn of the spinal cord. I study this sensory circuit and aim to understand the mechanisms that govern normal (protective) touch and pain, and how following injury or disease pain can become chronic (neuropathic pain).
My research has two avenues;
- I use non-native designer ion channels and pre-clinical genetic models to target and silence sensory function in healthy and chronic pain conditions. These designer ion channels function as an off-switch in pain transmission. My research aims to identify which population(s) of sensory neurons are critical for driving neuropathic pain, and to identify novel, druggable, targets in these key populations. In addition, I am developing these tools as innovative gene therapies that can silence abnormal activity in human IPSC derived sensory neurons, as a means to treat chronic pain.
- I am interested in how native ion channels and membrane transporters function in the sensory nervous system (such as Nav1.7, NCX3, SLC45A4), particularly in nociception and chronic pain. Understanding the role of native ion channels and transporters may offer new opportiunities to develop novel therapeutics for chronic pain.
To investigate these questions my research uses a wide range techniques including: Histology, molecular biology, viral construct design, chemogenetic silencing, patch-clamp electrophysiology and skin-nerve primary afferent recordings.
Key publications
-
Journal article
Perez-Sanchez J. et al, (2023), Science Translational Medicine, 15
-
Journal article
Middleton SJ. et al, (2021), Brain
-
Journal article
Middleton SJ. et al, (2021), Brain, 144, 1312 - 1335
-
Journal article
Middleton SJ. et al, (2023), Pain, Publish Ahead of Print
-
Journal article
Trendafilova T. et al, (2022), Neuron, 110, 2571 - 2587.e13
Recent publications
-
Journal article
Semizoglou E. et al, (2025), The Journal of Physiology
-
Preprint
Middleton SJ. et al, (2024)
-
Preprint
Semizoglou E. et al, (2024)
-
Journal article
Perez-Sanchez J. et al, (2023), Science Translational Medicine, 15
-
Journal article
Middleton SJ. et al, (2023), Pain, Publish Ahead of Print
-
Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons
Journal article
Kim HW. et al, (2023), Pain
-
Journal article
Sanchez JP. et al, (2023)
-
Journal article
Trendafilova T. et al, (2022), Neuron, 110, 2571 - 2587.e13
-
Journal article
Middleton SJ. et al, (2021), Brain
-
Journal article
Middleton SJ. et al, (2021), Journal of Anatomy